Fresenius Medical Care returns to Dax 40 Index

Core Viewpoint - Fresenius Medical Care will rejoin the DAX 40, the top tier of the German Stock Index, effective December 27, 2024, highlighting the company's recovery and strategic execution [5][7]. Company Overview - Fresenius Medical Care is the leading global provider of products and services for individuals with kidney diseases, serving approximately 4.1 million patients worldwide who regularly undergo dialysis treatment [6]. - The company operates a network of 3,732 dialysis clinics, providing treatments for around 308,000 patients globally [6]. - Fresenius Medical Care is also a major supplier of dialysis products, including dialysis machines and dialyzers [6]. Historical Context - The company was previously a member of the DAX since September 1999 but has been listed in the Mid-Cap DAX (MDAX) since March 2023, which tracks the 50 largest companies below the DAX 40 [7].